Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Kalydeco
Pharma
Vertex's Trikafta posted megablockbuster sales in 202
Vertex snared $7.57 billion in product revenues for 2021, signaling a 22% increase year over year.
Fraiser Kansteiner
Jan 27, 2022 9:55am
Vertex CEO touts Trikafta launch in 'mic drop' earnings call
Jan 31, 2020 9:17am
Vertex is 'humming' with triple combo launch Trikafta underway
Oct 30, 2019 4:44pm
Vertex ushers in CF triple combo era with Trikafta approval
Oct 21, 2019 6:42pm
Vertex: NHS England will have to do better with CF drugs offer
Jul 17, 2018 12:15pm
Patients wait as Vertex, U.K. officials argue over Orkambi price
Jul 9, 2018 12:25pm
